We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Integumen Plc | LSE:SKIN | London | Ordinary Share | GB00BMGWZY29 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 28.00 | 28.00 | 29.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Apr 2021 to Apr 2024
By Ian Walker
Deepverge PLC said Thursday that its enhanced monitoring equipment is to be installed as part of the U.K. Government's national Covid-19 infrastructure trial.
The environmental and life-sciences company said the equipment is worth 480,000 pounds ($659,520) and it expects to get revenue from installations next fiscal year, provided the trial is successful.
The trial is expected to last until the end of February 2022.
The multiple-unit installation consists of six upgraded Microtox toxicity monitoring and new models of the Microtox PD range for SARS-CoV-2 and other pathogen monitoring, Deepverge said.
"Deepverge is well-placed to capitalize on current and future opportunities to work with governments, industries bodies and private companies to create a co-ordinated solution, not only to the current global pandemic but also future health challenges," Chief Executive Gerry Brandon said.
Shares at 0952 GMT were up 2.25 pence, or 8.5%, at 28.75 pence.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
October 28, 2021 06:13 ET (10:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Integumen Chart |
1 Month Integumen Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
